TheOrdre des médecins ensures that the probity, morality, competence and dedication of doctors in the exercise of their profession are maintained, whether or not they are general practitioners or holders of a state or private diploma. The Order also guarantees the quality of patient care.
In the field of medical research, this private-law institution ensures that clinicians and all other parties involved comply strictly with the Code of Ethics. As part of its supervisory role, the OIQ verifies that the work carried out by the promoter - the pharmaceutical company or research laboratory - truly contributes toimproving the quality ofcare and the overall management of patients.
The Ordre des Médecins also assesses the nature and content of agreements between doctors and pharmaceutical companies. The institution ensures the regulatory compliance of these agreements with the ethical rules of the profession. In France, this prior inspection is part of the anti-gift law established by Ordinance no. 2017-49 of January 19, 2017.
This text sets out a clear regulatory framework for benefits offered by individuals and establishments that manufacture or market healthcare products or services. These regulations have been put in place to avoid any conflict of interest between pharmaceutical manufacturers and healthcare professionals.
In its assessment, the Ordre des Médecins takes a particular interest in the benefits offered to doctors, researchers and medical students by companies operating in the healthcare sector. Remuneration, expenses and other gifts likely to influence the moral and scientific integrity of research work are considered illicit.
The anti-gifts law does, however, authorize a number of derogations relating to compensation and remuneration for research activities, the valorization of research, scientific advice or evaluation. For example, students of general medicine who carry out research activities may receive benefits in connection with the preparation of a diploma.
